Pacemaker Timing Cycles and ECG Interpretation

A surface electrocardiogram can look deceptively simple when a pacemaker is present. A paced spike followed by a broad QRS may be easy to recognise, yet the timing that produced it often depends on several interacting intervals. Lower-rate limits, atrioventricular delay, refractory periods, sensing windows and manufacturer-specific algorithms can all alter the appearance of a tracing without indicating device malfunction.

For clinicians working across Australia, this matters in emergency departments, general practice, cardiology clinics and device follow-up services. A patient from regional New South Wales may present to a small hospital with an unfamiliar pacing pattern, while a person reviewed in a metropolitan electrophysiology service in Melbourne or Brisbane may have a complex dual-chamber or cardiac resynchronisation system. Understanding the timing cycle helps clinicians interpret the ECG before interrogating the generator.

The basic timing cycle

A pacemaker usually begins its timing cycle with a sensed or paced atrial or ventricular event. The device then waits for programmed intervals before delivering another stimulus. In a single-chamber ventricular system, the lower-rate interval is the central concept: if no intrinsic ventricular beat is detected within that interval, ventricular pacing occurs.

For example, a programmed lower rate of 60 beats per minute corresponds to a basic cycle length of approximately 1000 milliseconds. This does not mean every QRS will be exactly one second apart. Hysteresis, rate response, sensor-driven pacing, rate smoothing and occasional upper-rate behaviour can produce longer or shorter intervals. The ECG should therefore be read as a record of device timing, not as a simple metronome.

In a dual-chamber pacemaker, an atrial event commonly starts an atrioventricular delay. The device allows time for intrinsic conduction, then stimulates the ventricle if no suitable ventricular depolarisation is sensed. A paced atrial event followed by a ventricular spike after a fixed interval suggests an AV sequential pacing strategy. A sensed atrial wave followed by pacing in the ventricle may indicate intact atrial sensing with absent or delayed native AV conduction.

Recognising atrial and ventricular pacing

Atrial pacing is identified by a small pacing spike before a P wave, although the spike may be subtle or hidden by atrial activity. The subsequent P-wave morphology can differ from sinus rhythm because the atrial impulse begins near the pacing lead rather than the sinoatrial node. The PR interval then reflects intrinsic AV conduction or the device’s programmed AV delay.

Ventricular pacing is usually more conspicuous. Right ventricular apical stimulation often produces a left bundle branch block-like QRS pattern, with a broad QRS and discordant ST-T changes. Septal or conduction-system pacing may produce a narrower or different morphology. The lead position, baseline conduction disease and myocardial activation pattern should all be considered before labelling an ECG abnormal.

When both chambers are paced, atrial and ventricular spikes may be separated by a programmed AV delay. If atrial activity is sensed shortly after a ventricular event, the next cycle may be governed by post-ventricular atrial refractory period rather than by visible pacing. This can create apparent pauses or unusual P-wave relationships that are explained by the device’s response to timing, not by a new arrhythmia.

How refractory periods change the tracing

Pacemaker sensing is selective. During a blanking period, the device intentionally ignores electrical signals to prevent oversensing of its own pacing stimulus or far-field activity. During a refractory period, the device may detect an event electrically but decline to use it to trigger pacing. These intervals are invisible on the surface ECG, yet their effects are often visible.

The post-ventricular atrial refractory period, or PVARP, is particularly important in dual-chamber systems. An atrial depolarisation that falls within PVARP may appear on the ECG but will not be tracked to the ventricle. If retrograde conduction follows ventricular pacing, the resulting retrograde P wave can be ignored safely. If the timing promotes repetitive atrial sensing and ventricular pacing, pacemaker-mediated tachycardia may develop.

A long PVARP can also contribute to apparent failure to track atrial activity. Conversely, a short or poorly matched refractory period may permit tracking of retrograde atrial signals. Clinicians should assess whether P waves are truly sensed and followed, rather than assuming that every visible atrial wave should produce a ventricular response.

Upper-rate behaviour and pacemaker Wenckebach

A dual-chamber device cannot track atrial activity indefinitely. The maximum tracking rate limits how quickly sensed atrial events can produce ventricular pacing. When the atrial rate rises above this limit, the device may lengthen the paced AV interval progressively, creating a pattern similar to Wenckebach behaviour. A P wave may then be followed by no ventricular pacing, even though the pacemaker is functioning as programmed.

On an ECG, this can resemble second-degree AV block. The distinction depends on the timing of the atrial events, the presence of pacing spikes, and the programmed device behaviour. Atrial tachycardia, flutter or sinus tachycardia can all expose the upper tracking limit. In a patient with exertional symptoms, rate-response settings and the upper sensor rate should be considered alongside native conduction.

Mode switching adds another layer. When the device detects atrial tachyarrhythmia, it may change from an atrial-tracking mode to a non-tracking mode to prevent rapid ventricular pacing. The ventricular rhythm may then appear slower and more regular than the atrial rhythm. This is clinically useful, but it can make the ECG look like unexplained AV dissociation unless device history and interrogation findings are available.

Algorithms that mimic conduction disease

Modern pacemakers often use algorithms to encourage intrinsic ventricular conduction. A device may periodically extend the AV delay or switch between pacing modes to determine whether native conduction is present. This can produce intermittent ventricular pacing, changing PR intervals and occasional pauses that are expected consequences of the programmed strategy.

Hysteresis is another common source of confusion. If the lower rate is set at 60 beats per minute with a hysteresis rate of 50, the pacemaker may allow the intrinsic rhythm to continue below the nominal base rate before intervening. The ECG can therefore show a slower escape rhythm followed by pacing, without implying battery depletion or lead failure.

Rate-responsive pacing introduces gradual changes in cycle length during activity. A patient walking through a hospital corridor in Perth may have a paced rate that rises according to an accelerometer or minute-ventilation sensor, while a resting tracing in the clinic shows the programmed lower rate. Sensor behaviour, sleep settings and mode changes should be reviewed before interpreting rate variation as atrial arrhythmia.

A practical approach in Australian practice

Begin with the ECG itself: identify pacing spikes, determine whether atrial and ventricular activity are sensed or paced, measure the intervals, and assess capture. Ask whether every stimulus is followed by the expected depolarisation. Failure of capture, inappropriate inhibition, undersensing and oversensing have different ECG patterns. A magnet response, device brand and implant history may help, but magnet behaviour varies and should not replace formal interrogation.

The clinical setting influences access to device expertise. In Sydney, Melbourne, Adelaide and Brisbane, hospitals may have dedicated pacing teams and same-day interrogation pathways. In rural Queensland, Western Australia or the Northern Territory, initial assessment may rely on remote support, manufacturer technical services and transfer protocols. Telehealth and remote monitoring can assist, but a symptomatic patient with syncope, chest pain or suspected lead displacement still requires urgent clinical evaluation.

Australia’s regulated device market includes systems approved through the Therapeutic Goods Administration, with programming platforms and lead combinations that differ between manufacturers. Medicare-funded care, public hospital pathways and private cardiology services may result in different follow-up arrangements. The most useful documentation is the patient’s device card, implant report, current medication list, last interrogation report and contact details for the managing service.

Interpretation should also account for the reason for pacing. A patient with complete AV block may be almost continuously ventricular paced, while someone with sinus node dysfunction may show predominantly atrial pacing and preserved native AV conduction. Cardiac resynchronisation therapy adds biventricular or conduction-system pacing considerations, including fusion and pseudofusion beats that can make capture difficult to judge from a single lead.

For clinicians and researchers developing educational or scientific material on device timing, the journal’s submission guidance outlines requirements for preparing relevant manuscripts and reviews. Questions about editorial processes or journal content can be directed through the editorial contact, particularly when a case involves an unusual electrocardiographic pacing pattern.

A disciplined reading of pacemaker ECGs begins with the timing cycle and ends with correlation to symptoms, device interrogation and prior tracings. Recognising programmed intervals prevents false diagnoses of AV block, atrial tachycardia or pacemaker failure, while careful attention to capture and sensing helps identify genuine problems. In every setting, document the rhythm, the device type if known, the suspected mechanism and the urgency of specialist review.